Trial Profile
An Open-label, One-sequence Study to Evaluate the Effect of Multiple Doses of Rifampicin on the Pharmacokinetics of YM150 (Darexaban) and Metabolites in Young Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jun 2014
Price :
$35
*
At a glance
- Drugs Darexaban (Primary) ; Rifampicin
- Indications Bacterial infections; Thrombosis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 02 Aug 2011 New trial record